Posts Categorized: MS News

Disability benefits assessments costs doubled

Source MS Society: A report by the National Audit Office has found disability benefit assessments have doubled in cost to £579 million a year. The spending watchdog also found targets are being missed and, despite more tests being done face-to-face, the quality continues to be inadequate.  Read on.

Multiple Sclerosis and Parkinson’s Tissue Bank

The Multiple Sclerosis and Parkinson’s Tissue Bank is a national collection of central nervous system (CNS) tissue samples donated by individuals with multiple sclerosis (MS), Parkinson’s disease and related neuroinflammatory and neurodegenerative conditions. The vision of the Tissue Bank is one that it shares with its funding charities, the Multiple Sclerosis Society and Parkinson’s UK… Read more »

New consultation on Personal Independence Payment (PIP)

Source MS Society: The Government has launched a consultation on suggested changes to thePersonal Independence Payment (PIP), focussing on how an individual’s reliance on aids and appliances is assessed. The consultation suggests a number of options including reductions to PIP or replacing it with with a one-off payment for those who receive the benefit solely… Read more »

Could vitamin D help repair myelin?

  Source MS Society: Scientists working at the University of Cambridge have discovered a proteinactivated by vitamin D could be involved in the myelin repair process. The study, published today in The Journal of Cell Biology, offers significant evidence vitamin D could be a possible treatment for MS in the future.  Read on.

Next week Panorama reports on repurposing cancer drug for MS

Source BBC: One hundred thousand people in the UK have multiple sclerosis, an incurable condition that can result in permanent disability. Panorama has exclusive access to patients pioneering a crossover cancer treatment that has enabled some MS sufferers with paralysis to regain their movement.  For more click here. 

Researchers grow retinal nerve cells in the lab

Source EurekAlert: Johns Hopkins researchers have developed a method to efficiently turn human stem cells into retinal ganglion cells, the type of nerve cells located within the retina that transmit visual signals from the eye to the brain. Death and dysfunction of these cells cause vision loss in conditions like glaucoma and multiple sclerosis.  Read… Read more »